Cuq Toulza, France

Pascal Leplatois


Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 117(Granted Patents)


Location History:

  • Cuq Toulsa, FR (1990)
  • Cuo Toulza, FR (1994)
  • Cuq Toulza, FR (1994 - 1997)

Company Filing History:


Years Active: 1990-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Pascal Leplatois

Introduction

Pascal Leplatois is a notable inventor based in Cuq Toulza, France. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic applications. With a total of 7 patents to his name, Leplatois has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Leplatois has developed a protein having interleukin 13 activity, which is crucial for various cytokine-related functions. This invention includes a recombinant DNA coding for this protein, which comprises a specific amino acid sequence. Another significant patent involves a new urate oxidase activity protein, which is characterized by a unique sequence and has potential applications in medicine. This invention also encompasses the genetic engineering tools necessary for its production.

Career Highlights

Throughout his career, Pascal Leplatois has worked with prominent companies, including Sanofi. His work has focused on innovative solutions that address critical health issues through biotechnology.

Collaborations

Leplatois has collaborated with notable professionals in his field, including Richard Legoux and Daniel Caput. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Pascal Leplatois is a distinguished inventor whose work in biotechnology has led to significant advancements in therapeutic proteins. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…